RHBDF2 and fatty liver disease: IRHOM2 palmitoylation decreases ubiquitinated degradation of IRHOM2 and promotes its activation and downstream MAP3K7-JNK signaling, leading to increased hepatic steatosis, inflammation, and collagen accumulation